Skip to main content

Pancreas.

28 studies recruiting right now, most recently updated first.

Open the Phase 2 page · a list of only those studies

Triangle is made by Triangle Health, Inc.

Pancreas28 studies

Metastatic Pancreatic Ductal Adenocarcinoma (Second Line)Phase 1/2NCT06904378

ONT01 + Gemcitabine and Nab-Paclitaxel

ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma

Washington University School of MedicineOpen the brief

Pancreatic Ductal Adenocarcinoma (PDAC)Phase 1NCT06639724Papers

Fostamatinib

Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer

University of California, San DiegoOpen the brief

Clinical trials: Phase 1 and Phase 2, explained